184 related articles for article (PubMed ID: 30924090)
1. Adhering to Ethical Benchmarks in Neurology Clinical Trials Using iPSCs.
Akabayashi A; Nakazawa E; Jecker NS
Neurotherapeutics; 2020 Apr; 17(2):606-608. PubMed ID: 30924090
[TBL] [Abstract][Full Text] [Related]
2. Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.
Fung RK; Kerridge IH
Bioethics; 2013 Feb; 27(2):89-96. PubMed ID: 21726264
[TBL] [Abstract][Full Text] [Related]
3. Ethical and Safety Issues of Stem Cell-Based Therapy.
Volarevic V; Markovic BS; Gazdic M; Volarevic A; Jovicic N; Arsenijevic N; Armstrong L; Djonov V; Lako M; Stojkovic M
Int J Med Sci; 2018; 15(1):36-45. PubMed ID: 29333086
[TBL] [Abstract][Full Text] [Related]
4. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
5. An eye to the future: Researchers debate best path for stem cell-derived therapies.
Chakradhar S
Nat Med; 2016 Feb; 22(2):116-9. PubMed ID: 26845400
[No Abstract] [Full Text] [Related]
6. Use of Embryonic Stem Cells to Treat Severe Eye Diseases.
Aznar J; Tudela J
Cuad Bioet; 2016; 27(90):241-7. PubMed ID: 27637197
[TBL] [Abstract][Full Text] [Related]
7. The decision on the "optimal" human pluripotent stem cell.
Rosner M; Schipany K; Hengstschläger M
Stem Cells Transl Med; 2014 May; 3(5):553-9. PubMed ID: 24692589
[TBL] [Abstract][Full Text] [Related]
8. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
9. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
10. Some Ethical Concerns About Human Induced Pluripotent Stem Cells.
Zheng YL
Sci Eng Ethics; 2016 Oct; 22(5):1277-1284. PubMed ID: 26276162
[TBL] [Abstract][Full Text] [Related]
11. Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening.
Aboul-Soud MAM; Alzahrani AJ; Mahmoud A
Cells; 2021 Sep; 10(9):. PubMed ID: 34571968
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cell (iPSCs) and their application in immunotherapy.
Jiang Z; Han Y; Cao X
Cell Mol Immunol; 2014 Jan; 11(1):17-24. PubMed ID: 24336163
[TBL] [Abstract][Full Text] [Related]
13. iPSCs, aging and age-related diseases.
Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
[TBL] [Abstract][Full Text] [Related]
14. Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies.
Barazzetti G; Hurst SA; Mauron A
Stem Cells Transl Med; 2016 Aug; 5(8):1058-66. PubMed ID: 27334488
[TBL] [Abstract][Full Text] [Related]
15. Stem cell therapy: challenges ahead.
Bhagavati S
Indian J Pediatr; 2015 Mar; 82(3):286-91. PubMed ID: 24992980
[TBL] [Abstract][Full Text] [Related]
16. [Application of induced pluripotent stem (iPS) cells for nerve injury in the central nervous system].
Kinoshita H
Masui; 2013 Mar; 62(3):259-64. PubMed ID: 23544326
[TBL] [Abstract][Full Text] [Related]
17. Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.
Kumar D; Anand T; Kues WA
Cell Biol Toxicol; 2017 Apr; 33(2):99-112. PubMed ID: 27900567
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cells: how they will change the practice of cardiovascular medicine.
Wong WT; Sayed N; Cooke JP
Methodist Debakey Cardiovasc J; 2013; 9(4):206-9. PubMed ID: 24298311
[TBL] [Abstract][Full Text] [Related]
19. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
Yoshihara M; Hayashizaki Y; Murakawa Y
Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
[TBL] [Abstract][Full Text] [Related]
20. Potential Role of Induced Pluripotent Stem Cells as Regenerative Medicine in Retinal Cell Damage.
Sun YJ; Pan YR; Fan B; Li GY
J Environ Pathol Toxicol Oncol; 2018; 37(4):305-316. PubMed ID: 30806237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
